Circ_0017274 acts on <scp>miR</scp> ‐637/ <scp>CDX2</scp> axis to facilitate cisplatin resistance in gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circ_0017274 acts on miR ‐637/ CDX2 axis to facilitate cisplatin resistance in gastric cancer

Published:2022-07-21 Issue:10 Volume:49 Page:1105-1115
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharma Physio

Author:

Xu Bing¹,Guo Jinjuan²,Chen Mei³

Affiliation:

1. Department of Pharmacy The First People's Hospital of Lianyungang Lianyungang China

2. Department of Pharmacy, The First Affiliated Hospital of Kangda College of Nanjing Medical University Lianyungang China

3. Medical Insurance Division, The First People's Hospital of Lianyungang Lianyungang China

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1440-1681.13692

Reference32 articles.

1. Updates on Management of Gastric Cancer

2. Clinical epidemiology of gastric cancer

3. Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention

4. Progress in the treatment of advanced gastric cancer

5. What make differences in the outcome of adjuvant treatments for resected gastric cancer?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel role of circRNAs in the drug resistance of gastric cancer: regulatory mechanisms and future for cancer therapy;Frontiers in Pharmacology;2024-09-09

2. Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer;Journal of Nanobiotechnology;2024-08-29

3. Non-coding RNA and Drug resistance in cholangiocarcinoma;Non-coding RNA Research;2024-03

4. Emerging roles of circular RNAs in tumorigenesis, progression, and treatment of gastric cancer;Journal of Translational Medicine;2024-02-27

5. A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer;Biomedicine & Pharmacotherapy;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3